HOME >> MEDICINE >> NEWS
Chemoprevention backgrounder: Working for a future of cancer chemoprevention

-cell lung cancer, also contain a lot of COX-2, possibly because of the body's natural immune reaction to the cancer. Lotan found this year that, like some retinoids, NSAIDs may be effective in controlling cancer because they push cancerous cells to self-destruct.

In the ongoing placebo-controlled trial, which has accrued 85 patients so far, Kurie takes a biopsy of lung cells before, after and during the six-month study to see if twice-daily 400 milligrams doses of celecoxib can reverse damage due to smoking. "It's a biomarker study in which we will be able to see evidence of activity quickly," he says. "If positive, we will move on to a national study."

Not only is the power of COX-2 inhibitors being tested at M. D. Anderson in the number one cancer killer, lung cancer, but in the second deadliest national cancer - colorectal cancer.

And so far, it already has been proven to have an effect in people who inherit a form of colon cancer known as familial adenomatous polyposis (FAP), in which hundreds of precancerous polyps form in the colon and rectum. In 1999, the Food and Drug Administration (FDA) approved the use of celecoxib for FAP patients, based on work conducted at M. D. Anderson and St. Marks Hospital in London. In the study, led by Patrick Lynch, M.D., celecoxib reduced the number of polyps by 30 percent.

"It was an important event in the field of chemoprevention," says Levin. Colorectal cancer prevention trials do not focus on cancer occurrence, because of time constraints, but rather look at the incidence of adenomatous (glandular) polyps, which are known to increase colon cancer risk.

Based on that study, Lynch, an associate professor in the Department of Gastrointestinal Medicine and Nutrition, is heading another international trial in FAP looking at use of celecoxib combined with eflornithine (DFMO), a drug used to treat African sleeping sickness, but which is suspected of having anti-cancer properties. '"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-792-0655
University of Texas M. D. Anderson Cancer Center
16-Nov-2004


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Cancer gene therapy news backgrounder: New ideas fuel next generation gene therapy research
2. Iressa news backgrounder: Testing of smart drug expands at M. D. Anderson Cancer Center
3. Cancer markers news backgrounder: Future of cancer diagnosis, treatment lies in tumor barcode
4. Working out may keep breast cells working well
5. PAHO Working With Affected Communities In Central America
6. Lupus Foundation Of America Awards Summer Internship To Student Working At Wistar Institute
7. Concerns over the future of childrens health care in British general practice
8. Engineers develop biowarfare sensing elements for future highly sensitive nerve-gas detectors
9. HIV vaccine trial breaks ground for future research
10. Climate change and the future of air travel
11. NIH action plan charts future challenges for liver disease research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... 2020 , ... As fall and winter swiftly approach and many businesses cut ... taken this time to expand and grow into a full-fledged natural health clinic over ... will be relaunching its brand new website, expanding its services menu and has recruited ...
(Date:8/31/2020)... PITTSBURGH (PRWEB) , ... August 31, 2020 , ... ... Allegheny Health Network (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) ... alternative for cardiac patients who have undergone open heart surgery. , The AGH/CMU ...
(Date:8/31/2020)... ... ... your dear friend has cancer? , It’s hard to hear your doctor say the words ... the shock wears off, the questions and fears can be overwhelming. , How should I ... Words are failing me. I’m scared. I want to DO something. , We’ve talked to ...
(Date:8/31/2020)... ... ... Want to get moving, break up your routine, and make a difference ... launch its fourth annual STEPtember campaign in the United States to raise funds and ... are at this moment — encouraging people to move in the ways that work ...
(Date:8/31/2020)... Colo. (PRWEB) , ... August 31, 2020 , ... ... provider of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – ... Responder Psychology . , Among the first of its kind in the ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... at Boulder’s Vance Lab ( https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted ... provide better protection against the COVID-19 virus than many other masks. Q&J face ...
(Date:9/2/2020)... ... ... U.S. Dermatology Partners is excited to welcome Board-Certified Dermatologist and ... Bethesda Dermatopathology Lab. , Jonathan Lee, MD grew up in the California Bay ... on to receive his M.D. with Honors from Harvard Medical School and pre-doctoral surgical ...
(Date:9/1/2020)... ... 2020 , ... Breast and ovarian cancers are common diseases that affect many ... cancers (about 7,500 women per year) and 10% of ovarian cancers (about 2,000 women ... genes are detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, ...
Breaking Medicine Technology:
Cached News: